116 filings
Page 4 of 6
8-K
zhmfamr
27 Jan 22
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides a Corporate Update
4:07pm
8-K
d6zhxh6oyn7
10 Jan 22
Other Events
7:11am
8-K
06c7qcjav3b
27 Oct 21
Other Events
7:01am
8-K
6uitjy3ql0rwvlcck
14 Oct 21
Nurix Therapeutics Reports Third Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
5:10pm
8-K
3bvr rs6403jc
30 Sep 21
Nurix Therapeutics Expands its Board of Directors with the Addition of Two Industry Leaders
7:08am
S-3ASR
m2uwyl4b
4 Aug 21
Automatic shelf registration
4:11pm
8-K
95e d4vokpe
13 Jul 21
Nurix Therapeutics Reports Second Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
4:12pm
8-K
lc9si uw3vz
9 Jul 21
Entry into a Material Definitive Agreement
4:27pm
8-K
ji86zxwevbj9mo507
21 Jun 21
Departure of Directors or Certain Officers
4:17pm
8-K
tiqik kj3u9l9
2 Jun 21
Regulation FD Disclosure
7:00am
8-K
06a56aax61ss
1 Jun 21
Nurix Therapeutics Appoints Industry Leader Clay Siegall, Ph.D., to its
4:11pm
8-K
vmih37 ehpvqbbb
10 May 21
Submission of Matters to a Vote of Security Holders
6:04am
8-K
jekqj
13 Apr 21
Nurix Therapeutics Reports First Quarter Fiscal 2021 Financial Results and Provides a Corporate Update
4:08pm
DEFA14A
7fkdr1owhuie
25 Mar 21
Additional proxy soliciting materials
6:08am
DEF 14A
f978f1
25 Mar 21
Definitive proxy
6:03am
424B4
16oplt6nw2unshgkprx
5 Mar 21
Prospectus supplement with pricing info
4:07pm